UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
18,007,620
Share change
-5,243,552
Total reported value
$62,299,462
Put/Call ratio
89%
Price per share
$3.46
Number of holders
75
Value change
-$34,426,346
Number of buys
37
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q3 2020

As of 30 Sep 2020, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,007,620 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, Invus Financial Advisors, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, EcoR1 Capital, LLC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC. This page lists 75 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.